Showing results (191-200 of 5,696) with videos related to
Sort By:
Pageof 570
Medical Oncology (Northwood, London, England)|September 29, 2022
Establishment and characterization of chemotherapy-enriched sphere-forming cells with stemness phenotypes as a new cell line (BAG50) of gastric carcinomaVahid Bagheri, Mehran Gholamin, Atena Mansouri, et al.Medical Oncology (Northwood, London, England)|September 29, 2022
Expression patterns and therapeutic implications of histone deacetylase-1 across carcinomas: a comprehensive molecular docking and MD simulation studyBader AlshehriMedical Oncology (Northwood, London, England)|September 29, 2022
CD36 accelerates the progression of hepatocellular carcinoma by promoting FAs absorptionLide Tao, Xiangmin Ding, Lele Yan, et al.Medical Oncology (Northwood, London, England)|September 29, 2022
SPLUNC1 regulates LPS-induced progression of nasopharyngeal carcinoma and proliferation of myeloid-derived suppressor cellsLing Tang, Ling Peng, Huai Liu, et al.Medical Oncology (Northwood, London, England)|September 29, 2022
Tumor immune microenvironment and systemic response in breast cancerKosuke Kawaguchi, Yurina Maeshima, Masakazu ToiMedical Oncology (Northwood, London, England)|September 29, 2022
Are we overtreating stage I triple-negative breast cancer in Ontario? A population-based retrospective epidemiological analysis using the ICES databaseKathryn Shum, Abdulkadir Hussein, Caroline HammMedical Oncology (Northwood, London, England)|September 29, 2022
Evaluation of lung adverse events with trastuzumab using the Japanese pharmacovigilance databaseYuko Kanbayashi, Mayako Uchida, Misui Kashiwagi, et al.Medical Oncology (Northwood, London, England)|September 29, 2022
Moxidectin induces autophagy arrest in colorectal cancerYushan Mao, Hanhan Xie, Dan Shu, et al.Medical Oncology (Northwood, London, England)|September 29, 2022
A critical review of datasets and computational suites for improving cancer theranostics and biomarker discoveryGayathri Ashok, Sudha RamaiahMedical Oncology (Northwood, London, England)|September 29, 2022
The role of HER2 alterations in clinicopathological and molecular characteristics of breast cancer and HER2-targeted therapies: a comprehensive reviewShafighe Asgari-Karchekani, Armin Aryannejad, Seied Asadollah Mousavi, et al.Pageof 570